Potential contribution of benzodiazepine abuse in the development of a bladder sarcomatoid carcinoma: A case report

Baio,Raffaele; Spiezia,Nicola; Marani,Carla; Schettini,Manlio

doi:10.3892/mco.2021.2394

Potential contribution of benzodiazepine abuse in the development of a bladder sarcomatoid carcinoma: A case report

Authors:
- Raffaele Baio
- Nicola Spiezia
- Carla Marani
- Manlio Schettini
View Affiliations

Affiliations: Department of Urology, University of Salerno, I‑84081 Salerno, Italy, Department of Urology, Private Hospital ‘Lourdes Clinic’, I‑80040 Naples, Italy, Department of Anatomopathology, San Carlo Hospital of Nancy, I‑00165 Rome, Italy
Published online on: September 13, 2021 https://doi.org/10.3892/mco.2021.2394
Article Number: 231
Copyright: © Baio et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Invasive urothelial carcinoma has a propensity for disparate differentiation and presentation of morphological variants. Sarcomatoid carcinoma (SaC) of the bladder is an extremely uncommon and aggressive variant of bladder cancer. An accurate diagnosis for this variant is necessary, but at times difficult. Immunohistochemistry can increase the diagnostic accuracy for SaC. The therapeutic approaches currently adopted for the treatment of SaC are similar to those used for the urothelial variant: Surgery, chemotherapy and radiation therapy. To date, however, there exists no standard treatment due to the lack of knowledge regarding the pathogenesis of SaC. Future research is required to focus on this rare histological tumor subtype in order to identify more effective treatment strategies. The present study reported an unusual case of bladder SaC in a woman aged 48 years, who was a non‑smoker with a long history of benzodiazepine abuse. Although saving the patient's life was a priority, it was also essential to consider her subsequent quality of life. For that reason, the patient underwent a cystectomy with orthotopic neobladder reconstruction using ileum, followed by chemotherapy. At the 7 month follow‑up, the patient was still alive, in complete remission and had normal bladder function. The present case report shows the potential contribution of benzodiazepine abuse in the development of a bladder sarcomatoid carcinoma, a rare variant of BC, whose early detection and accurate diagnosis are key to attaining satisfactory treatment outcomes and a favorable prognosis for patients.

View Figures

View References

1	Lucon AM and Falci R Jr: Câncer de Bexiga. Vol II. Lopes AC (ed). Tratado de ClínicaMédica, São Paulo, pp2923-2930, 2006.
2	Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A and Abnet CC: Association between smoking and risk of bladder cancer among men and women. JAMA. 306:737–745. 2011.PubMed/NCBI View Article : Google Scholar
3	Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG and Sherif A: EAU guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2013 guidelines. Eur Urol. 65:778–792. 2014.PubMed/NCBI View Article : Google Scholar
4	Eble JN, Sauter G, Sesterhenn I and Epstein JI (eds): Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. IARC Press, Lyon, pp99-133, 2004.
5	Wang J, Gillaspie C, Kunadharaju R, Talmon GA and Enke C: Sarcomatoid urothelial carcinoma: A single cancer center experience. World J Oncol. 2:175–180. 2011.PubMed/NCBI View Article : Google Scholar
6	DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 64:252–271. 2014.PubMed/NCBI View Article : Google Scholar
7	Silva CB, Alves MC, Ribeiro JC, Garcia P and Santos AR: Carcinoma Sarcomatóide da Bexiga. Acta Urológica. 23:61–64. 2006.
8	Venyo AK and Titi S: Sarcomatoid variant of urothelial carcinoma (carcinosarcoma, spindle cell carcinoma): A review of the literature. ISRN Urol. 2014(794563)2014.PubMed/NCBI View Article : Google Scholar
9	Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J and Rouprêt M: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013. Eur Urol. 64:639–653. 2013.PubMed/NCBI View Article : Google Scholar
10	Ploeg M, Aben KK and Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol. 27:289–293. 2009.PubMed/NCBI View Article : Google Scholar
11	Sung MT, Wang M, MacLennan GT, Eble JN, Tan PH, Lopez-Beltran A, Montironi R, Harris JJ, Kuhar M and Cheng L: Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: Evidence for a common clonal origin with divergent differentiation. J Pathol. 211:420–430. 2007.PubMed/NCBI View Article : Google Scholar
12	Humphrey PA, Moch H, Cubilla AL, Ulbright TM and Reuter VE: The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: Prostate and bladder tumours. Eur Urol. 70:106–119. 2016.PubMed/NCBI View Article : Google Scholar
13	Mallik AU, Rahman MZ and Sarker MMR: Sarcomatoid carcinoma of urinary bladder-a case report. Banglajol. 4:28–29. 2010.
14	Kaufman DS, Shipley WU and Feldman AS: Bladder cancer. Lancet. 374:239–249. 2009.PubMed/NCBI View Article : Google Scholar
15	Sobin LH, Gospodarowicz MK and Wittekind C: TNM Classification of Malignant Tumours. 7th edition. Wiley-Liss, New York, NY, 2010.
16	Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP and Lin DW: Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol. 178:2302–2306. 2007.PubMed/NCBI View Article : Google Scholar
17	Stopper H, Körber C, Spencer DL, Kirchner S, Caspary WJ and Schiffmann D: An investigation of micronucleus and mutation induction by oxazepam in mammalian cells. Mutagenesis. 8:449–455. 1993.PubMed/NCBI View Article : Google Scholar
18	Karmali RA, Volkman A, Muse P and Louis TM: The influence of diazepam administration in rats bearing the R3230AC mammary carcinoma. Prostaglandins Med. 3:193–198. 1979.PubMed/NCBI View Article : Google Scholar
19	Miyawaki I, Moriyasu M, Funabashi H, Yasuba M and Matsuoka N: Mechanism of clobazam-induced thyroidal oncogenesis in male rats. Toxicol Lett. 145:291–301. 2003.PubMed/NCBI View Article : Google Scholar
20	Iida M, Anna CH, Hartis J, Bruno M, Wetmore B, Dubin JR, Sieber S, Bennett L, Cunningham ML, Paules RS, et al: Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis. 24:757–770. 2003.PubMed/NCBI View Article : Google Scholar
21	Iqbal U, Nguyen PA, Syed-Abdul S, Yang HC, Huang CW, Jian WS, Hsu MH, Yen Y and Li YJ: Is long-term use of benzodiazepine a risk for cancer? Medicine (Baltimore). 94(e483)2015.PubMed/NCBI View Article : Google Scholar
22	Xu W, Tamim H, Shapiro S, Stang MR and Collet JP: Use of antidepressants and risk of colorectal cancer: A nested case-control study. Lancet Oncol. 7:301–308. 2006.PubMed/NCBI View Article : Google Scholar
23	Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S and Shapiro S: Relation of benzodiazepine use to the risk of selected cancers: Breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver. Am J Epidemiol. 141:1153–1160. 1995.PubMed/NCBI View Article : Google Scholar
24	Kripke DF and Langer RD: Evidence for harm, comment on ‘Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: A population-based case-control study’. Br J Clin Pharmacol. 78:186–187. 2013.PubMed/NCBI View Article : Google Scholar
25	Cronin-Fenton DP, Riis AH, Lash TL, Dalton SO, Friis S, Robertson D and Sørensen HT: Antidepressant use and colorectal cancer risk: A Danish population-based case-control study. Br J Cancer. 104:188–192. 2011.PubMed/NCBI View Article : Google Scholar
26	Kao CH, Sun LM, Su KP, Chang SN, Sung FC, Muo CH and Liang JA: Benzodiazepine use possibly increases cancer risk: A population-based retrospective cohort study in Taiwan. J Clin Psychiatry. 73:e555–e560. 2012.PubMed/NCBI View Article : Google Scholar
27	Coogan-PF Rosenberg L, Palmer JR, Strom BL, Stolley PD, Zauber AG and Shapiro S: Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States). Cancer Causes Control. 11:839–845. 2000.PubMed/NCBI View Article : Google Scholar
28	Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML and Bostwick DG: Carcinosarcoma and sarcomatoid carcinoma of the bladder: Clinicopathological study of 41 cases. J Urol. 159:1497–1503. 1998.PubMed/NCBI View Article : Google Scholar
29	Bansal A, Kumar N and Sharma SC: Sarcomatoid variant of urothelial carcinoma of the urinary bladder. J Cancer Res Ther. 9:571–573. 2013.PubMed/NCBI View Article : Google Scholar
30	Mittal V, Rupala KK, Yadav R and Suryavanshi M: Giant sarcomatoid carcinoma with osseous metaplasia from urinary bladder diverticulum. Indian J Surg Oncol. 8:436–439. 2017.